MTA2 and Alzheimer disease: Confirming this possibility, WB analysis of proteins re-extracted from the DNase-treated RIPA pellet revealed strong RD3 immunoreactivity with PiD Tau and AD Tau, with only faint immunoreactivity with PSP and CBD Tau (Supp.